Von dem Buch Therapy-Resistant Schizophrenia: 26 (Advances in Biological Psychiatry) haben wir 2 gleiche oder sehr ähnliche Ausgaben identifiziert!
Falls Sie nur an einem bestimmten Exempar interessiert sind, können Sie aus der folgenden Liste jenes wählen, an dem Sie interessiert sind:
100%: Elkis, Meltzer, Ebert, Editor: H. Elkis, Editor: H.Y. Meltzer: Therapy-Resistant Schizophrenia: 26 (Advances in Biological Psychiatry) (ISBN: 9783805595124) 2010, Erstausgabe, in Englisch, auch als eBook.Nur diese Ausgabe anzeigen…
33%: H. Elkis, H. Y. Meltzer (Editor), Contribution by W. P. Kaschka, Contribution by D. Ebert, Contribution by K. P. Ebmeier, Contri: Therapy-Resistant Schizophrenia (Advances in Biological Psychiatry) (ISBN: 9783805595117) 2010, S Karger Pub, in Deutsch, Broschiert.
Nur diese Ausgabe anzeigen…
Nur diese Ausgabe anzeigen…
Therapy-Resistant Schizophrenia: 26 (Advances in Biological Psychiatry)
10 Angebote vergleichen
| Preise | 2013 | 2015 | 2018 |
|---|---|---|---|
| Schnitt | € 0,00 | € 38,55 | € 88,06 |
| Nachfrage |
1
Therapy-Resistant Schizophrenia: 26 (Advances in Biological Psychiatry) (2010)
EN NW FE EB DLISBN: 9783805595124 bzw. 3805595123, in Englisch, 200 Seiten, S. Karger, neu, Erstausgabe, E-Book, elektronischer Download.
Lieferung aus: Vereinigte Staaten von Amerika, E-Book zum Download.
The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment. This volume presents the latest research and recommendations on the definition, causes and therapy of treatment-resistant schizophrenia (TRS). Methods for identification and optimal management of TRS are reviewed. Clozapine and other atypical antipsychotic drugs which are the primary treatment for TRS, as well as non-pharmacologic treatments such as transcranial magnetic stimulation, cognitive behavior therapy and ECT are discussed in depth. Potential causative factors and identifying features such as genetic factors, poor premorbid functioning, longer duration of untreated psychosis, and biological measures such as structural and functional brain abnormalities are also reviewed in depth in the present volume. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2010-07-29, Freigegeben: 2010-07-29, Studio: S. Karger, Verkaufsrang: 1141145.
The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment. This volume presents the latest research and recommendations on the definition, causes and therapy of treatment-resistant schizophrenia (TRS). Methods for identification and optimal management of TRS are reviewed. Clozapine and other atypical antipsychotic drugs which are the primary treatment for TRS, as well as non-pharmacologic treatments such as transcranial magnetic stimulation, cognitive behavior therapy and ECT are discussed in depth. Potential causative factors and identifying features such as genetic factors, poor premorbid functioning, longer duration of untreated psychosis, and biological measures such as structural and functional brain abnormalities are also reviewed in depth in the present volume. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2010-07-29, Freigegeben: 2010-07-29, Studio: S. Karger, Verkaufsrang: 1141145.
2
Therapy-Resistant Schizophrenia: 26 (Advances in Biological Psychiatry) (2010)
EN NW FE EB DLISBN: 9783805595124 bzw. 3805595123, in Englisch, 200 Seiten, S. Karger, neu, Erstausgabe, E-Book, elektronischer Download.
Lieferung aus: Deutschland, E-Book zum Download.
The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment. This volume presents the latest research and recommendations on the definition, causes and therapy of treatment-resistant schizophrenia (TRS). Methods for identification and optimal management of TRS are reviewed. Clozapine and other atypical antipsychotic drugs which are the primary treatment for TRS, as well as non-pharmacologic treatments such as transcranial magnetic stimulation, cognitive behavior therapy and ECT are discussed in depth. Potential causative factors and identifying features such as genetic factors, poor premorbid functioning, longer duration of untreated psychosis, and biological measures such as structural and functional brain abnormalities are also reviewed in depth in the present volume. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2010-07-29, Freigegeben: 2010-07-29, Studio: S. Karger.
The psychotic symptoms of up to 30% of schizophrenic patients do not respond adequately to treatment with antipsychotic drugs, other than clozapine. These refractory patients are generally among the most disabled of all people with schizophrenia and require special assessment and treatment. This volume presents the latest research and recommendations on the definition, causes and therapy of treatment-resistant schizophrenia (TRS). Methods for identification and optimal management of TRS are reviewed. Clozapine and other atypical antipsychotic drugs which are the primary treatment for TRS, as well as non-pharmacologic treatments such as transcranial magnetic stimulation, cognitive behavior therapy and ECT are discussed in depth. Potential causative factors and identifying features such as genetic factors, poor premorbid functioning, longer duration of untreated psychosis, and biological measures such as structural and functional brain abnormalities are also reviewed in depth in the present volume. Kindle Edition, Ausgabe: 1, Format: Kindle eBook, Label: S. Karger, S. Karger, Produktgruppe: eBooks, Publiziert: 2010-07-29, Freigegeben: 2010-07-29, Studio: S. Karger.
3
Therapy-Resistant Schizophrenia (2010)
DE NW EB DLISBN: 9783805595124 bzw. 3805595123, in Deutsch, S. Karger, S. Karger, S. Karger, neu, E-Book, elektronischer Download.
Lieferung aus: Deutschland, in-stock.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
4
Therapy-Resistant Schizophrenia
DE NWISBN: 9783805595124 bzw. 3805595123, in Deutsch, neu.
Lieferung aus: Vereinigtes Königreich Großbritannien und Nordirland, Versandkostenfrei.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
5
Therapy-Resistant Schizophrenia (Advances in Biological Psychiatry)
DE HC USISBN: 9783805595117 bzw. 3805595115, in Deutsch, S Karger Pub, gebundenes Buch, gebraucht.
Lieferung aus: Vereinigte Staaten von Amerika, Versandkostenfrei.
Von Händler/Antiquariat, purplewhale123 [59676976], aurora, IL, U.S.A.
3805595115 Item in good condition and ready to ship!
Von Händler/Antiquariat, purplewhale123 [59676976], aurora, IL, U.S.A.
3805595115 Item in good condition and ready to ship!
6
Therapy-Resistant Schizophrenia (Advances in Biological Psychiatry) (2010)
DE HC USISBN: 9783805595117 bzw. 3805595115, in Deutsch, S Karger Pub, gebundenes Buch, gebraucht.
Von Händler/Antiquariat, HPB-Dallas [54223947], Dallas, TX, U.S.A.
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Die Beschreibung dieses Angebotes ist von geringer Qualität oder in einer Fremdsprache. Trotzdem anzeigen
Lade…